X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,528,941 | -43.5% | 7,824,717 | +0.5% | 0.00% | – |
Q2 2023 | $15,107,052 | +299.7% | 7,787,140 | +79.2% | 0.00% | – |
Q1 2023 | $3,779,551 | +6.3% | 4,344,311 | +21.3% | 0.00% | – |
Q4 2022 | $3,555,326 | -35.2% | 3,580,389 | +11.6% | 0.00% | – |
Q3 2022 | $5,486,000 | +695.1% | 3,208,103 | +348.6% | 0.00% | – |
Q2 2022 | $690,000 | -39.7% | 715,175 | +9.5% | 0.00% | – |
Q1 2022 | $1,144,000 | -46.5% | 653,185 | -30.0% | 0.00% | – |
Q4 2021 | $2,137,000 | -56.8% | 933,240 | -0.1% | 0.00% | – |
Q3 2021 | $4,942,000 | -15.3% | 934,352 | +4.1% | 0.00% | – |
Q2 2021 | $5,834,000 | -8.0% | 897,641 | +21.9% | 0.00% | – |
Q1 2021 | $6,343,000 | +34.2% | 736,602 | +0.2% | 0.00% | – |
Q4 2020 | $4,726,000 | -2.7% | 734,966 | +2.4% | 0.00% | – |
Q3 2020 | $4,857,000 | -27.7% | 717,392 | -0.4% | 0.00% | – |
Q2 2020 | $6,716,000 | -9.1% | 720,625 | -2.5% | 0.00% | – |
Q1 2020 | $7,391,000 | -4.1% | 739,048 | +2.5% | 0.00% | – |
Q4 2019 | $7,711,000 | +11.9% | 720,686 | +33.0% | 0.00% | – |
Q3 2019 | $6,888,000 | -12.2% | 541,925 | +3.7% | 0.00% | – |
Q2 2019 | $7,842,000 | +422.1% | 522,811 | +506.0% | 0.00% | – |
Q1 2019 | $1,502,000 | – | 86,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |